Login
E-mail
Password
Mostra password
Ricorda
Password dimenticata?
Iscriviti gratuitamente
Registrazione
Registrazione
Parametri
Parametri
Quotazioni dinamiche 
OFFON

I Leader della Finanza

Ultime notizieSocietąMercatiEconomia & ForexMaterie PrimeTassiLeader della FinanzaPro. della FinanzaAgendaSettori 
HomeTutte le notizieLe notizie pił letteBiografie dei Leader della finanza
Portrait de Troy E. Wilson
Etą : 51
Patrimonio pubblico : 49 789 018 USD
Principali societą : Avidity Biosciences, Inc. - Kura Oncology, Inc. - Puma Biotechnology, Inc.
Riassunto 
Founder of 5 different companies, notably: Kura Oncology, Inc., Avidity Biosciences, Inc. and Ambrx, Inc. Troy E. Wilson is an entrepreneur and businessperson who has been the head of 9 different companies and is Non-Executive Chairman of Avidity Biosciences, Inc. (which he founded in 2012), Chairman, President & Chief Executive Officer at Kura Oncology, Inc. (which he founded in 2014), Executive Chairman at Wellspring Biosciences LLC and Executive Chairman at Abintus Bio, Inc. Troy E. Wilson is also on the board of Puma Biotechnology, Inc. and Managing Member at Araxes Pharma LLC.

He previously was President for Wildcat Discovery Technologies, Inc. (he founded the company), Chief Business Officer for Ambrx, Inc. (he founded the company in 2003), Founding Partner of Presidio Partners, Chairman, President & Chief Executive Officer of Zeta Acquisition Corp. III, President, Chief Executive Officer & Director at Intellikine LLC (he founded the company in 2007), Chief Executive Officer of Takeda Pharmaceuticals U.S.A., Inc. and Vice President-Business Development of Novartis Institute for Functional Genomics, Inc.

Troy E. Wilson received an undergraduate degree and a doctorate from the University of California, Berkeley and a graduate degree from New York University.


Posti e reponsabilitą di Troy E. Wilson 
NomeTitolo Da
Avidity Biosciences, Inc.
(Prodotti farmaceutici)
Non-Executive Chairman 2021
Puma Biotechnology, Inc.
(Biotecnologia)
Independent Director 2013
Kura Oncology, Inc.
(Biotecnologia)
Chairman, President & Chief Executive Officer 2018
Wellspring Biosciences LLC Executive Chairman 2019
Abintus Bio, Inc. Executive Chairman 2020
Araxes Pharma LLC Managing Member 2019


Participazioni di Troy E. Wilson 
NomeAzioni%Valorizzazione
Kura Oncology, Inc. (KURA)
(Biotecnologia)
1 659 9682,50%27 256 675 USD
Avidity Biosciences, Inc. (RNA)
(Prodotti farmaceutici)
994 9192,12%22 385 678 USD
Puma Biotechnology, Inc. (PBYI)
(Biotecnologia)
28 7580,071%146 666 USD


Troy E. Wilson: network personale 
Le notizie pił lette 
24/11ELON MUSK: Musk vende azioni Tesla per 1,05 miliardi di dollari e compra 2,15 milioni di azioni
MR
30/11JACK DORSEY: Jack Dorsey insegue cripto, fintech sogno post Twitter
MR
24/11JAMIE DIMON: Jamie Dimon scherza sul fatto che JPMorgan sopravviverà al partito comunista cinese
MR
01/12JACK DORSEY: Square, guidata da Dorsey, si ribattezza in Block in un cenno alla blockchain
MR
24/11ERIK NORDSTROM: L'utile di Nordstrom manca le stime su problemi di supply-chain, le azioni crollano
MR
29/11ANIL AMBANI: La banca centrale dell'India avvia la procedura di fallimento contro Reliance Capital; co per conformarsi
MR
18/11MIUCCIA PRADA: Prada fissa un obiettivo di fatturato di 4,5 miliardi di euro, per aumentare l'e-commerce
MR
29/11JACK DORSEY: Twitter, si dimette Ceo Jack Dorsey
RE
23/11STUART ROSE: Gli azionisti di Morrisons appoggiano l'acquisizione di CD&R per 10 miliardi di dollari
MR
19/11AXEL WEBER: ESCLUSIVA - Ubs, Mustier in shortlist come successore presidente Weber - fonti
RE
Pił notizie


© 2021 People and Ownership :   
Troy E. Wilson : connessioni